Date: 2011-03-11
Type of information: Private placement
Company: Biotie Therapies (Finland)
Investors: Finnish and international institutional and strategic investors.
Amount: €27 million
Funding type: private placement
Planned used:
Others: Biotie Therapies has executed a private placement of shares in the amount of EUR €27 million that has been fully subscribed for. A total of 35,230,000 newly issued and 14,747,084 treasury shares were offered in the Offering at a subscription price of €0.54 per share. Subsequent to the completion of the Offering, Biotie's cash, cash equivalents and short term investments will amount to over € 45 million. As a result of the issue of new shares and the sale of the treasury shares, the share capital of Biotie will be increased by € 26,987,625.36. After the registration of the new shares with the Finnish Trade Register and the registration of the share capital increase related to the new shares and the sale of the treasury shares, the share capital of Biotie will be €165,919,181.95, the total number of shares 387,594,457, and the number of votes outstanding 372,682,302 (taking into consideration the treasury shares held by Biotie and its subsidiaries).
Therapeutic area: Neurodegenerative diseases - Mental diseases
